BACKGROUND
Continuous glucose monitoring (CGM) has been shown to be beneficial in persons with type 1 diabetes and others with insulin-treated type 2 diabetes, but its role in the treatment of persons with type 2 diabetes not being treated with insulin has needed further study.
METHODS
In a 26-week trial conducted at...
Tamara K. Oser, T. Martens, K. Ruedy et al.· New England Journal of Medic...· 0 citations
CGM-informed basal insulin optimization with a prototype of Dexcom Smart Basal was associated with improvements in glycemic control and treatment satisfaction in adults with T2D, with a favorable safety profile, and the system may help overcome clinical inertia and support individualized insulin titration in real-world...
S. Oser, C. Crystal, K. Hames et al.· Diabetes Therapy· 0 citations
Randomized and real-world studies demonstrate that AID systems significantly improve A1C and time in range while minimizing hypoglycemia, without increasing treatment complexity or patient burden, and position AID as a practical and effective strategy to overcome long-standing therapeutic inertia in type 2 diabetes.
Z. Tariq, Grazia Aleppo, Anders L. Carlson et al.· Endocrine Practice· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.